Agilent Technologies, Inc.
General ticker "A" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $35.9B (TTM average)
Agilent Technologies, Inc. follows the US Stock Market performance with the rate: 59.1%.
Estimated limits based on current volatility of 1.6%: low 147.61$, high 152.53$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2025-09-30, amount 0.25$ (Y0.67%)
- Total employees count: 17900 (-1.1%) as of 2024
- China accounted for 18.7% of revenue in the fiscal year ended 2024-10-31
- US accounted for 34.5% of revenue in the fiscal year ended 2024-10-31
- Top business risk factors: Economic downturns and volatility, Currency fluctuations, Supply chain disruptions, Regulatory and compliance, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-10-31 to 2026-10-31
- 2024-10-31 to 2025-10-31 estimated range: [121.40$, 171.05$]
- 2025-10-31 to 2026-10-31 estimated range: [134.75$, 187.77$]
Financial Metrics affecting the A estimates:
- Negative: with PPE of 25.1 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 22.86 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of -0.72 <= 0
- Positive: 0.33 < Operating cash flow per share per price, % of 4.55
- Positive: Interest expense per share per price, % of 0.25 <= 0.79
- Positive: 41.86 < Shareholder equity ratio, % of 49.79 <= 63.39
- Negative: Industry earnings per price (median), % of -1.37 <= 0
Short-term A quotes
Long-term A plot with estimates
Financial data
| YTD | 2022-10-31 | 2023-10-31 | 2024-10-31 |
|---|---|---|---|
| Operating Revenue | $6,848.00MM | $6,833.00MM | $6,510.00MM |
| Operating Expenses | $5,230.00MM | $5,483.00MM | $5,022.00MM |
| Operating Income | $1,618.00MM | $1,350.00MM | $1,488.00MM |
| Non-Operating Income | $-114.00MM | $-11.00MM | $33.00MM |
| Interest Expense | $84.00MM | $95.00MM | $96.00MM |
| R&D Expense | $467.00MM | $481.00MM | $479.00MM |
| Income(Loss) | $1,504.00MM | $1,339.00MM | $1,521.00MM |
| Taxes | $250.00MM | $99.00MM | $232.00MM |
| Profit(Loss)* | $1,254.00MM | $1,240.00MM | $1,289.00MM |
| Stockholders Equity | $5,305.00MM | $5,845.00MM | $5,898.00MM |
| Inventory | $1,038.00MM | $1,031.00MM | $991.00MM |
| Assets | $10,532.00MM | $10,763.00MM | $11,846.00MM |
| Operating Cash Flow | $1,312.00MM | $1,772.00MM | $1,751.00MM |
| Capital expenditure | $291.00MM | $298.00MM | $378.00MM |
| Investing Cash Flow | $-338.00MM | $-310.00MM | $-1,258.00MM |
| Financing Cash Flow | $-1,372.00MM | $-930.00MM | $-752.00MM |
| Earnings Per Share** | $4.19 | $4.22 | $4.44 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.